Gripovac 3
Withdrawn
This medicine's authorisation has been withdrawn
inactivated influenza-A virus
MedicineVeterinaryWithdrawn
Latvian is available via eTranslation, the European Commission's machine translation service.
Translate to Latvian | Important information about machine translation
- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
The marketing authorisation for Gripovac 3 has been withdrawn at the request of the marketing authorisation holder.
Product information
Latest procedure affecting product information:R/0005
04/12/2014
Product details
- Name of medicine
- Gripovac 3
- Active substance
- inactivated influenza-A virus
- International non-proprietary name (INN) or common name
- inactivated influenza-A virus
- Species
- Pigs
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QI09AA03
Pharmacotherapeutic group
ImmunologicalsTherapeutic indication
Active immunisation of pigs from the age of 56 days onwards including pregnant sows against swine influenza caused by subtypes H1N1, H3N2 and H1N2 to reduce clinical signs and viral lung load after infection.
Onset of immunity: 7 days after primary vaccination.
Duration of immunity: 4 months in pigs vaccinated between the age of 56 and 96 days and 6 months in pigs vaccinated for the first time at 96 days and above.
Active immunisation of pregnant sows after finished primary immunisation by administration of a single dose 14 days prior to farrowing to develop high colostral immunity which provides clinical protection of piglets for at least 33 days after birth.
News on Gripovac 3
This page was last updated on